Patent 11633405 was granted and assigned to TherapeuticsMD on April, 2023 by the United States Patent and Trademark Office.
This disclosure provides pharmaceutical compositions for delivering estradiol to a subject in need thereof, as well as methods of administering the compositions, and methods of using them.